SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-015012
Filing Date
2022-03-25
Accepted
2022-03-25 07:53:20
Documents
63
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_relmadatherap.htm   iXBRL 10-K 998810
2 CONSENT OF MARCUM LLP f10k2021ex23-1_relmada.htm EX-23.1 2220
3 CERTIFICATION f10k2021ex31-1_relmada.htm EX-31.1 7699
4 CERTIFICATION f10k2021ex31-2_relmada.htm EX-31.2 7764
5 CERTIFICATION f10k2021ex32-1_relmada.htm EX-32.1 3434
6 CERTIFICATION f10k2021ex32-2_relmada.htm EX-32.2 3356
  Complete submission text file 0001213900-22-015012.txt   4581327

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rlmd-20211231.xsd EX-101.SCH 50072
8 XBRL CALCULATION FILE rlmd-20211231_cal.xml EX-101.CAL 20596
9 XBRL DEFINITION FILE rlmd-20211231_def.xml EX-101.DEF 220613
10 XBRL LABEL FILE rlmd-20211231_lab.xml EX-101.LAB 452467
11 XBRL PRESENTATION FILE rlmd-20211231_pre.xml EX-101.PRE 232697
57 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_relmadatherap_htm.xml XML 419805
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39082 | Film No.: 22768256
SIC: 2834 Pharmaceutical Preparations